D Moradpour1, A Cerny, M H Heim
1Department of Medicine II, University of Freiburg, Freiburg i. Br., Germany.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Hepatitis C virus (HCV) infection causes liver disease worldwide. New antiviral and immunotherapeutic strategies are being explored to inhibit HCV replication and enhance immune response, potentially complementing current treatments.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: